<p>/PRNewswire/ -- Clordisys Solutions, LLC 是一家領先的二氧化氯氣體合同滅菌服務提供商，是環氧乙烷（EO）的成熟替代方案，今天宣佈兩位前 Sterigenics 領導者 Cody Lane 和 Kenneth Allen 加入其執行團隊。</p>
<p>這一領導層擴展反映了 Clordisys 在商業運營、擴展產能以及支持其現有合同滅菌平台和未來設施日益增長的需求方面的持續發展。</p>
<p>Lane 和 Allen 的加入進一步鞏固了 Clordisys 作為複雜醫療設備和製藥產品的商業規模合同滅菌提供商的地位。</p>
<p><strong>Cody Lane</strong>，業務發展總監，加入 Clordisys 以指導客户在可行性、驗證以及長期商業和合同關係方面的參與。Lane 擁有超過 14 年的技術和商業經驗，涵蓋生物製品、醫療設備和合同滅菌。他的背景包括在 Sterigenics 工作超過六年，支持製藥和醫療設備製造商在環氧乙烷、伽馬射線、X 射線和電子束滅菌方式下的需求，以及在生物製品製造、研發支持和內部滅菌操作方面的豐富經驗。</p>
<p>Lane 在滅菌科學、監管期望和實際實施方面的專業知識支持客户從開發項目過渡到經過驗證的、可擴展的商業處理，特別是在有效的 EO 替代品需求持續增長的情況下。</p>
<p><strong>Kenneth Allen</strong>，運營副總裁，擁有超過 33 年的生命科學和醫療技術領域的領導經驗，包括在 Sterigenics、Arrow International、Boston Scientific、Fresenius Medical Care、bioMérieux、AstraZeneca 和 Integra Life Sciences 擔任運營、質量和總管理等高級職務。Allen 負責 Clordisys 合同滅菌業務的商業運營，強化了一個專注於產量、可靠性和可擴展性的運營基礎。</p>
<p>Allen 的經驗包括直接領導環氧乙烷、伽馬射線和蒸汽滅菌設施，以及大規模的整改工作、質量體系轉型、數字化現代化和運營卓越計劃。他的運營領導支持持續的產能擴展和嚴謹的執行，隨着額外的滅菌設施投入使用。</p>
<p>“這些新增成員代表了 Clordisys 持續增長的重要一步，” Clordisys 首席執行官 Mark Lecher 表示。“Cody 和 Ken 帶來了深厚的滅菌專業知識、運營紀律和行業信譽。他們的領導增強了我們為客户提供一致性能、監管信心和可擴展產能的能力。”</p>
<p>領導層擴展緊隨 Clordisys 新網站和品牌形象更新的推出，反映了公司作為專注於安全、可擴展性和運營卓越的合同滅菌合作伙伴的持續演變。</p>
<p>隨着領導層深度和運營實力的增強，Clordisys 繼續推動二氧化氯氣體滅菌作為全球醫療設備和製藥製造商可行的高產量 EO 替代方案。</p>
<p>聯繫方式：Emily Lorcheim，ClorDiSys，電話：908-236-4100，[email protected]，50 Tannery Rd, Suite 1, Branchburg, NJ 08876</p>
<p>來源：ClorDiSys Solutions Inc</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEwJk5ld3NJdGVtSWQ9Tlk4NDg4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTAxMzAxUFJfTkVXU19VU1BSX19fX19OWTg0ODgz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEwJk5ld3NJdGVtSWQ9Tlk4NDg4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTAxMzAxUFJfTkVXU19VU1BSX19fX19OWTg0ODgz"/></p>

<p>Clordisys Solutions, LLC 通過引入前 Sterigenics 的領導者 Cody Lane 和 Kenneth Allen 來擴展其領導團隊，以支持其合同滅菌業務的增長。Lane 擔任業務發展總監，將增強客户參與度，而 Allen 擔任運營副總裁，將負責商業運營。這一領導層擴展旨在加強 Clordisys 在合同滅菌市場的地位，特別是在醫療設備和製藥領域，因為對二氧化氯氣滅菌替代環氧乙烷的需求正在增加</p>

<p>, /PRNewswire/ -- Clordisys Solutions, LLC, a leading provider of chlorine dioxide gas contract sterilization services and an established alternative to ethylene oxide (EO), today announced the addition of Cody Lane and Kenneth Allen, two former Sterigenics leaders, to its executive team.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Clordisys Solutions, LLC 是一家領先的二氧化氯氣體合同滅菌服務提供商，是環氧乙烷（EO）的成熟替代方案，今天宣佈兩位前 Sterigenics 領導者 Cody Lane 和 Kenneth Allen 加入其執行團隊。</p>
</div><p>This leadership expansion reflects Clordisys' continued scaling of its commercial operations, expanded capacity, and ability to support increasing demand across its existing contract sterilization platform and future facilities.</p>
<div class="lb-trans"><p>這一領導層擴展反映了 Clordisys 在商業運營、擴展產能以及支持其現有合同滅菌平台和未來設施日益增長的需求方面的持續發展。</p>
</div><p>The addition of Lane and Allen further strengthens Clordisys' position as a commercial-scale contract sterilization provider for complex medical device and pharmaceutical products.</p>
<div class="lb-trans"><p>Lane 和 Allen 的加入進一步鞏固了 Clordisys 作為複雜醫療設備和製藥產品的商業規模合同滅菌提供商的地位。</p>
</div><p><strong>Cody Lane</strong>, Director of Business Development, joins Clordisys to guide customer engagement across feasibility, validation, and long-term commercial and contractual relationships. Lane brings more than 14 years of technical and commercial experience spanning biologics, medical devices, and contract sterilization. His background includes more than six years at Sterigenics supporting pharmaceutical and medical device manufacturers across ethylene oxide, gamma, X-ray, and E-beam sterilization modalities, as well as extensive experience in biologics manufacturing, R&amp;D support, and in-house sterilization operations.</p>
<div class="lb-trans"><p><strong>Cody Lane</strong>，業務發展總監，加入 Clordisys 以指導客户在可行性、驗證以及長期商業和合同關係方面的參與。Lane 擁有超過 14 年的技術和商業經驗，涵蓋生物製品、醫療設備和合同滅菌。他的背景包括在 Sterigenics 工作超過六年，支持製藥和醫療設備製造商在環氧乙烷、伽馬射線、X 射線和電子束滅菌方式下的需求，以及在生物製品製造、研發支持和內部滅菌操作方面的豐富經驗。</p>
</div><p>Lane's expertise in sterilization science, regulatory expectations, and practical implementation supports customers transitioning from development programs into validated, scalable commercial processing, particularly as demand for effective EO alternatives continues to grow.</p>
<div class="lb-trans"><p>Lane 在滅菌科學、監管期望和實際實施方面的專業知識支持客户從開發項目過渡到經過驗證的、可擴展的商業處理，特別是在有效的 EO 替代品需求持續增長的情況下。</p>
</div><p><strong>Kenneth Allen</strong>, Vice President of Operations, brings more than 33 years of leadership experience across life sciences and medtech, including senior roles in operations, quality, and general management at Sterigenics, Arrow International, Boston Scientific, Fresenius Medical Care, bioMérieux, AstraZeneca, and Integra Life Sciences. Allen oversees commercial operations across Clordisys' contract sterilization business, reinforcing an operational foundation focused on throughput, reliability, and scalability.</p>
<div class="lb-trans"><p><strong>Kenneth Allen</strong>，運營副總裁，擁有超過 33 年的生命科學和醫療技術領域的領導經驗，包括在 Sterigenics、Arrow International、Boston Scientific、Fresenius Medical Care、bioMérieux、AstraZeneca 和 Integra Life Sciences 擔任運營、質量和總管理等高級職務。Allen 負責 Clordisys 合同滅菌業務的商業運營，強化了一個專注於產量、可靠性和可擴展性的運營基礎。</p>
</div><p>Allen's experience includes direct leadership of ethylene oxide, gamma, and steam sterilization facilities, as well as large-scale remediation efforts, quality system transformation, digital modernization, and operational excellence initiatives. His operational leadership supports continued capacity expansion and disciplined execution as additional sterilization facilities come online.</p>
<div class="lb-trans"><p>Allen 的經驗包括直接領導環氧乙烷、伽馬射線和蒸汽滅菌設施，以及大規模的整改工作、質量體系轉型、數字化現代化和運營卓越計劃。他的運營領導支持持續的產能擴展和嚴謹的執行，隨着額外的滅菌設施投入使用。</p>
</div><p>&#34;These additions represent an important step in Clordisys' continued growth,&#34; said Mark Lecher, Chief Executive Officer of Clordisys. &#34;Cody and Ken bring deep sterilization expertise, operational discipline, and industry credibility. Their leadership enhances our ability to deliver consistent performance, regulatory confidence, and scalable capacity for our customers.&#34;</p>
<div class="lb-trans"><p>“這些新增成員代表了 Clordisys 持續增長的重要一步，” Clordisys 首席執行官 Mark Lecher 表示。“Cody 和 Ken 帶來了深厚的滅菌專業知識、運營紀律和行業信譽。他們的領導增強了我們為客户提供一致性能、監管信心和可擴展產能的能力。”</p>
</div><p>The leadership expansion closely follows the launch of Clordisys' new website and refreshed brand identity, reflecting the company's continued evolution as a contract sterilization partner focused on safety, scalability, and operational excellence.</p>
<div class="lb-trans"><p>領導層擴展緊隨 Clordisys 新網站和品牌形象更新的推出，反映了公司作為專注於安全、可擴展性和運營卓越的合同滅菌合作伙伴的持續演變。</p>
</div><p>With increased leadership depth and operational strength, Clordisys continues to advance chlorine dioxide gas sterilization as a viable, high-throughput EO alternative for medical device and pharmaceutical manufacturers worldwide.</p>
<div class="lb-trans"><p>隨着領導層深度和運營實力的增強，Clordisys 繼續推動二氧化氯氣體滅菌作為全球醫療設備和製藥製造商可行的高產量 EO 替代方案。</p>
</div><p>Contact: Emily Lorcheim, ClorDiSys, Phone: 908-236-4100, [email protected], 50 Tannery Rd, Suite 1, Branchburg, NJ 08876</p>
<div class="lb-trans"><p>聯繫方式：Emily Lorcheim，ClorDiSys，電話：908-236-4100，[email protected]，50 Tannery Rd, Suite 1, Branchburg, NJ 08876</p>
</div><p>SOURCE ClorDiSys Solutions Inc</p>
<div class="lb-trans"><p>來源：ClorDiSys Solutions Inc</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEwJk5ld3NJdGVtSWQ9Tlk4NDg4MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTAxMzAxUFJfTkVXU19VU1BSX19fX19OWTg0ODgz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY84883&amp;Transmission_Id=202602101301PR_NEWS_USPR_____NY84883&amp;DateId=20260210"/></p>

13:01 ETClordisys Strengthens Leadership Team with Addition of Former Sterigenics Leaders to Support Growth and Continued Scaling of Contract Sterilization Operations

Clordisys 通過引入前 Sterigenics 的領導者來加強其領導團隊，以支持合同滅菌業務的增長和持續擴展